Dosimetric study of the 15mm ROPES eye plaque-Reference-Cited by-同舟云学术

Dosimetric study of the 15mm ROPES eye plaque

Published:2004-11-19 Issue:12 Volume:31 Page:3330-3336
ISSN:0094-2405
Container-title:Medical Physics
language:en
Short-container-title:Med. Phys.

Author:

Granero D.,Pérez-Calatayud J.,Ballester F.,Casal E.,de Frutos J. M.

Publisher

Wiley

Subject

General Medicine

Reference35 articles.

1. Primary malignant melanoma of the uvea: Radioactive plaque therapy and other treatment modalities;Petrovich,1993

2. Radioactive plaque therapy in the management of primary malignant ocular melanoma: An overview;Petrovich;Endocurietherapy/Hyperthermia Oncology,1990

3. Geant4-A simulation toolkit;Agostinelli;Nucl. Instrum. Methods Phys. Res. A,2003

4. http://geant4.web.cern.ch/geant4/

5. I125 eye plaque dose distribution including penumbra characteristics;de la Zerda;Med. Phys.,1996

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monte Carlo‐based dosimetry of proposed bi‐radionuclide (¹²⁵I and ¹⁰⁶Ru/¹⁰⁶Rh) eye plaque: A feasibility study;Medical Physics;2024-06-27

2. A practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo calculation in ocular brachytherapy using 125I COMS plaques;Brachytherapy;2024-05

3. Transitioning from a COMS‐based plaque brachytherapy program to using eye physics plaques and plaque simulator treatment planning system: A single institutional experience;Journal of Applied Clinical Medical Physics;2023-01-13

4. A study comparing baseline and best-corrected visual acuity after iodine-125 episcleral brachytherapy in uveal melanoma;Journal of Contemporary Brachytherapy;2023

5. Measured, calculated, and egs_brachy I‐125 dose distributions in a gold plaque for retinoblastoma treatment;Medical Physics;2022-07-18